Production process | Lot | Vaccines | Protection ratio (negative/all) |
---|---|---|---|
Batch culture | 1 | 5.5 μg PCV2-VLPs | 10/10 |
2 | 5.5 μg PCV2-VLPs | 10/10 | |
3 | 5.5 μg PCV2-VLPs | 9/10 | |
Fed-batch culture | 1 | 5.5 μg PCV2-VLPs | 9/10 |
2 | 5.5 μg PCV2-VLPs | 9/10 | |
3 | 5.5 μg PCV2-VLPs | 10/10 | |
Positive control | 1 | Commercial inactived vaccine | 9/10 |
Negative control | 1 | Sf9 cells infected by wild baculovirus | 2/10 |
Blank control | 1 | PBS | 2/10 |